Almac Group

Operating from state-of-the-art facilities across the US, Europe, and the UK, Almac Pharma Services is a member of the Almac Group and is an established CDMO partner to the global pharmaceutical and biotechnology industry, employing over 2,000 highly skilled professionals. With more than 57 years of experience, we deliver scientifically robust, flexible solutions to support drug development from early-phase through to commercialisation.

At APS PharmSci, we are showcasing our deep expertise in pharmaceutical development and oral dose formulation—supporting clients to transform complex molecules into viable clinical and commercial products. Our development scientists work in purpose-designed facilities to optimise formulations, enabling rapid progression from candidate selection through First-in-Human studies and into later-stage clinical development.

Our integrated development offering spans:

• Pre-formulation and formulation development
• Biopharmaceutics and process optimisation
• Clinical trial manufacturing and scale-up
• Late-phase development and commercial readiness

This seamless approach enables a smooth transition through the development lifecycle, reducing risk and accelerating timelines.

Almac is a recognised leader in the manufacture and primary packaging of oral dosage forms, including tablets, capsules, and powders, supporting all stages of clinical development and commercial supply. We complement this with flexible, customised secondary packaging solutions, including specialist capabilities for complex products such as ultra-low temperature therapies.

We also bring proven experience in advanced therapy medicinal products (ATMPs). As one of the first EU CDMOs to support gene therapy product launches, we currently support approximately 25% of EU-approved or pre-registration gene therapies, underlining our capability in handling complex and sensitive products.

Beyond manufacture, we provide end-to-end supply chain support, including packaging design, labelling, global distribution, and launch readiness—ensuring continuity from development through to commercial supply.

At Almac, we operate as a true partner—working collaboratively with our clients to deliver tailored, science-led solutions that mitigate risk, enhance efficiency, and ultimately accelerate the successful development and delivery of innovative medicines to patients worldwide.

Download our Brochures

Meet the Team at PharmSci 2026

Dr Terry Ernest

Director, Manufacturing Science & Technology, Almac Pharma Services

Dr Terry Ernest is a recognised leader in pharmaceutical drug product development, with more than 30 years’ experience spanning early research through to global commercialisation. Formerly a Director and Senior Fellow, Product Development at GSK, Terry has played a pivotal role in delivering oral and sterile drug products across multiple therapeutic areas and dosage forms, including immediate‑ and modified‑release formulations, oral liquids and age‑appropriate medicines. He is widely regarded as a subject‑matter expert in paediatric and patient‑centric formulation design, contributing to international consortia such as EuPFIand IQ, and to the review of regulatory guidance on behalf of industry.

Maciej Krause

BD Manager EU & APAC, Almac Pharma Services

Maciej Krause supports pharmaceutical and biotech companies across the UK and APAC regions in advancing their drug development and commercialisation programmes. With over 15 years’ experience in the pharmaceutical sector, Maciej combines a strong technical background in manufacturing and process engineering with extensive expertise in marketing and business development. His career has spanned early-stage development through to commercial supply, enabling him to provide strategic, customer-focused solutions tailored to complex drug development needs.

Dr Sander van den Ban

Director, Operations – Manufacturing, Almac Pharma Services

Sander has over 24 years’ experience in the pharmaceutical industry, having held a number of senior technical roles at GSK before being appointed Head of Formulation Sciences at Reckitt. Sander holds an MSc in Chemical Engineering and Bioprocess Technology and has overall responsibility for F&D Operations at the Charnwood facility.

Centrix Pharma Solutions

Centrix Pharma Solutions are your development partner. When you need experienced, skilled professional input for your pharmaceutical development programme, Centrix delivers the focused attention, technical expertise, and collaborative spirit to transform your scientific vision into patient focused treatments.

For more information, please visit us at:

Meet the Team at PharmSci 2026

Abdul Ershad

Michele Ghirardi

Colorcon

Colorcon is a world leader in the development, supply and technical support of film coating systems, modified release technologies, specialty excipients and functional packaging for the healthcare industries. Our innovative products and technologies are complemented by our value-added services, supporting all phases of solid dose design, development, and manufacture.

For more information, please visit us at:

Meet the Team at PharmSci 2026

Stéphane Rault
Technology Manager – Functional Packaging

Alex Scott
Senior Area Technical Manager

Jason Teckoe
Director – Film Coatings Technical Strategy

Evonik

Evonik’s Health Care business is an innovation hub for leading global pharmaceutical, medical device and nutraceutical companies. Our broad, versatile portfolio of functional excipients, technologies, and contract manufacturing (CDMO) services for oral and parenteral dosage forms positions us a global leader for advanced drug delivery. We also provide end-to-end CDMO capabilities for small molecule active pharmaceutical ingredients (APIs), highly potent APIs and intermediates, and supply high-quality, innovative cell culture solutions. With a trusted global network of manufacturing sites, laboratories, and development centers, we deliver reliable, scalable solutions to more than 1,000 customers worldwide – including 90 percent of the world’s top life-science companies. Our proven track record reflects our commitment to enabling breakthroughs that improve health and quality of life.

Download our Brochures

Meet the Team at PharmSci 2026

Dominic Walsh
Business Manager for United Kingdom and Ireland, Evonik Health Care

Nina Hauschildt
Principal Scientist Formulation & Application Services, Evonik Health Care

Gattefossé

Since 1880, Gattefossé has been sharing scientific know-how towards improving well-being, health and beauty around the world. We design, produce and market high-quality pharmaceutical excipients and natural cosmetic ingredients, based on a deep understanding of our customer’s needs. Gattefossé Pharmaceuticals offer innovative lipid excipients and personalized technical support, provided by fully trained experts to accelerate customers’ development programs, for pharmaceutical and veterinary drugs, as well as dietary supplements.

Download our Brochures

Meet the Team at PharmSci 2026

Charles Adesuyi
Business Development – Pharma (UK/IRE)

Takunda Tsvakayi
Customer Support Assistant

Genvolt

Genvolt is a multinational engineering firm and has been a trailblazer in the technology space for over three decades. Renowned for our innovative solutions, we have recently established ourselves as a leading global player in the manufacture of emerging pioneering pharmaceutical research equipment. Our commitment to excellence is reflected in our extensive collaborations with researchers and institutions globally, particularly in the field of Electrohydrodynamic Atomisation (EHDA).

Genvolt has consistently pushed the boundaries of innovation. Our expertise in Pharmaceutical Engineering Technology has driven the design and development of several low-cost, high-value base platform technologies— built upon groundbreaking collaborative projects that sit at the intersection of science and innovation. These are targeted at revolutionising drug delivery and pharmaceutical research and the advancement of electrospinning and electrospraying technologies, with bespoke end-user design and interface.

Genvolt’s success is built on our dynamic exploration of cutting-edge technology and collaborative excellence. We pride ourselves on our partnerships with leading global researchers and institutions, which have positioned us at the forefront of EHDA research. These collaborations are not only advancing scientific knowledge but also translating into practical, high-impact solutions for the pharmaceutical industry.

Meet our team of experts who are ready to provide personalised advice and support tailored to your specific requirements. Experience live demonstrations of our products and see firsthand how they can benefit your laboratory and research projects.

We invite all attendees to visit our booth to learn more about how Genvolt’s advanced technologies can drive your research forward. Whether you are involved in pharmaceuticals, biotechnology, or academic research, our solutions are crafted to meet your highest expectations and facilitate groundbreaking discoveries.

Meet the Team at PharmSci 2026

Mark Jacques
Special Projects Engineer

Stuart Morgan
Managing Director

Hiden Isochema LTD

Hiden Isochema is a world leader in the design and manufacture of sorption instruments for research, development and production applications in materials science and related fields. We offer a range of fully automated gravimetric, manometric and breakthrough sorption analyzers for determining the equilibria and kinetics of gas and vapor sorption by solid and liquid materials. Our product range includes dynamic vapor sorption (DVS) analyzers, dedicated membrane permeation analyzers and unique climate control systems.

Download our Brochures

Meet the Team at PharmSci 2026

Paul senior
Product Manager

Intertek

With 30+ years of experience in formulation and nasal drug development, Intertek offers advanced drug delivery systems for targeted and controlled release of novel therapies or vaccines. Our expertise spans both large and small molecules, supporting key decision-making with performance testing, method development/ validation, stability, E&L, CMC support, and clinical manufacturing. Intertek offers a broad range of analytical services including characterization for biologics, DNA therapies, peptides, cell and gene therapies, liposome, LNP and nano-particle technologies alongside solubility, dissolution, particle morphology and other inhaled delivery performance aspects (delivered dose, aerodynamic droplet size distribution, spray pattern etc.)

Meet the Team at PharmSci 2026

Antonino Bianco
Proposal Manager

Sara Pinto
Business Development Manager

Hannah Stafford
Team Leader

MDPI

A pioneer in scholarly, open access publishing, Multidisciplinary Digital Publishing Institute (MDPI) has supported academic communities since 1996. Based in Basel, Switzerland, MDPI has the mission to foster open scientific exchange in all forms, across all disciplines. Our 539 diverse and open access journals, including 530 peer-reviewed journals and 9 conference journals, are supported by more than 295,000 academic experts who share our mission, values, and commitment to providing high-quality service for our authors.

Meet the Team at PharmSci 2026

Nebojsa Salaj
Deputy Managing Editor

Amy Stainthorp
Scientific Editor

Pion

Pion supports the development of lifesaving and life-enhancing drugs by providing tools for drug developers, formulations scientists, and pharmaceutical production. For early-stage drug developers, our cutting-edge analytical technologies and services enable in vitro measurements of solubility, permeability, pKa and lipophilicity, providing essential data to improve candidate selection and formulations decisions for both oral and subcutaneous dosage forms.

Download our Brochures

Meet the Team at PharmSci 2026

Karl Box

Karl Box, Chief Scientific Officer – Europe, Pion Inc. (UK) Ltd

Karl Box has served as Chief Scientific Officer (Europe) at Pion (UK) since 2020. He is involved in scientific and chemistry related functions within the company, as well as supporting commercial activities and business development. His expertise is in the field of physicochemical measurements, where he has forged a successful career in the development of new instrumentation and assays for supporting drug discovery and development. Karl earned his BSc (Hons) in Chemistry in 1989 from the University of Bath.

Karl is an established speaker at many international scientific meetings and conferences. He has over 40 peer reviewed publications in scientific journals and has published on many topics, including solubility and lipophilicity and its relationship to the Biopharmaceutical Classification System, and explored the ideas of improving a compounds classification through the use of supersaturation and solubility enhancement strategies, all high-agenda items for the oral biopharmaceutics and drug delivery sectors.

Hayley Watson

Hayley Watson, Sales Manager, EMEIA, Pion Inc. (UK) Ltd

Hayley Watson is currently Sales Manager for EMEIA and has been part of the commercial team at Pion since 2018, after originally joining the team as an Applications Chemist in 2016. Hayley leads a team of regional sales representatives and channel partners to support commercial activities across Europe, India and Japan. Prior to joining Pion, Hayley spent 5 years as an Analytical & PhysChem Scientist with UCB in Slough. Hayley earned her MChem (Hons) in Chemistry in 2012 from the University of Bath.

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with over 120,000 colleagues worldwide. Our mission is to enable our customers to make the world healthier, cleaner, and safer.

We offer comprehensive solutions for pharmaceutical extrusion applications from formulation development, to scale-up and commercial manufacturing.

Hot melt extrusion (HME) is a key technology that can address challenges in pharmaceuticals where API solubility is critical as well as produce alternative drug delivery systems such as subcutaneous, solid implants for controlled-release treatment.

Continuous granulation reduces the issues often encountered in batch manufacturing and can increase product quality considerably. With online monitoring, continuous manufacturing also enables drugs to be released as soon as they’re manufactured.

Our demonstration labs can assist you in realising your specific application needs and goals.

Download our Brochures

Meet the Team at PharmSci 2026

Kevin Barber

Ytron-Quadro (UK) Limited

Established in 1984, Ytron-Quadro (UK) Limited have been providing processing equipment to the pharmaceutical industry for more than 40 years.

The company was originally founded to represent YTRON mixing and dispersing equipment and Quadro, the originator of the Comil, conical mill.

Ytron-Quadro now represents Fitzpatrick for milling and roller compaction, VMI mixing systems for cream and lotion formulations and Labocontrole sampling devices for powders and liquids.

Recently we have started working with MATCON in the UK whose IBC cone valve and bin blending systems are designed to ensure consistent performance and containment whether handling powders, granules or tablets.  

Meet the Team at PharmSci 2026

Ben Bradley
Sales Manager

Jon Youles
Managing Director

We offer various sponsorship packages tailored to meet your marketing objectives, see detailed information below. Exhibit spaces are also available for companies looking to showcase their latest products and technologies.

If you have any questions please send us an email to info@apsgb.co.uk and one of our team will come back to you.